Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2025-12-24 @ 9:14 PM
NCT ID: NCT04447404
Eligibility Criteria: Inclusion Criteria: * Hospitalized with moderate, severe, or early critical COVID-19 illness diagnosed by RT- PCR * Acute liver injury (including acute on chronic liver disease) or acute kidney injury or moderate COVID-19 pneumonia Exclusion Criteria: * Critical COVID-19 illness (MAP \< 60 mm Hg, on mechanical ventilator for ≥ 5 days) * On maintenance hemodialysis or peritoneal dialysis * Child Pugh C cirrhosis * Hepatorenal syndrome * Ascites and/or hepatic encephalopathy * History of end stage renal disease or CKD with eGFR \< 15 mL/min/1.73m2 * Women who are pregnant or breast feeding * Receipt of other concomitant experimental therapies
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT04447404
Study Brief:
Protocol Section: NCT04447404